Recommendations include raising standards of approval from “reasonable assurance” of safety to “substantial evidence” of safety, ensuring that implantable and life-sustaining devices do not go through the fast-tracked 510(k) process, requiring devices approved based on a recalled device are automatically reviewed for safety, implementation of a national unique identifier system to track safety issues, enabling the FDA to use its recall authority more effectively and providing the FDA with authority to call for longer term post-market studies. The letter comes before the reauthorization of the Medical Device User Fee Act.
Related Articles on Medical Devices:
FDA Opens Comment Period on Device Reclassification Process
Global Harmonization Task Force Issued Device Classification Guidance
10 Recent FDA Drug and Medical Device Decisions
